The CNS as a target for peptides and peptide-based drugs
- 31 October 2006
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 3 (6) , 707-712
- https://doi.org/10.1517/17425247.3.6.707
Abstract
(2006). The CNS as a target for peptides and peptide-based drugs. Expert Opinion on Drug Delivery: Vol. 3, No. 6, pp. 707-712. doi: 10.1517/17425247.3.6.707Keywords
This publication has 38 references indexed in Scilit:
- Passage of erythropoietic agents across the blood–brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfaEuropean Journal of Pharmacology, 2004
- Changing the chemokine gradient: CINC1 crosses the blood–brain barrierJournal of Neuroimmunology, 2001
- Bioavailability and Transport of Peptides and Peptide Drugs into the BrainPeptides, 1997
- Passage of peptides across the blood-brain barrier: Pathophysiological perspectivesLife Sciences, 1996
- Strategies for delivery of peptide drugs to the central nervous system: exploiting molecular structureJournal of Controlled Release, 1994
- Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat modelAmerican Journal of Physiology-Cell Physiology, 1993
- A brain-to-blood carrier-mediated transport system for small, N-Tyrosinated peptidesPharmacology Biochemistry and Behavior, 1984
- CSF-plasma relationships for DSIP and some other neuropeptidesPharmacology Biochemistry and Behavior, 1983
- Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeabilityJournal of Medicinal Chemistry, 1980
- Lipid Solubility and Drug Penetration of the Blood Brain BarrierExperimental Biology and Medicine, 1974